The Inactivated Vaccines Market was valued at US$ 40.6 billion in 2023 and is projected to grow at a CAGR of 5.7% from 2024 ...

Zydus Lifesciences introduces India's first quadrivalent influenza vaccine, VaxiFlu-4, for protection against four new virus strains as per WHO recommendations. The vaccine, developed at Zydus's ...

Pandemic influenza remains a significant global health threat, as signalled by the circulation and cross-species transmission of avian influenza A(H5N1) viruses from the clade 2.3.4.4b, including ...

CLEVELAND, Ohio — Eggs are disappearing from store shelves due to shortages caused by the avian flu outbreak, but never fear ...

An in-house reverse-genetics generated H5N9 inactivated vaccine (SEP-22- N9) was evaluated for its vaccine efficacy in ...

In the type segment of the influenza vaccine market, the inactivated influenza vaccine category generated a significant revenue share in the influenza vaccine market in 2024. Notable influenza ...

Commercially available vaccines include egg- or cell-based inactivated, live attenuated and recombinant influenza vaccines. To develop more effective vaccines, a deeper understanding of influenza ...

VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives. The Quadrivalent Inactivated ...

Zydus on Wednesday announced that it is ready to launch the season’s first India’s Flu protection as per WHO recommended composition of quadrivalent influenza virus vaccines for use in the 2025 ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

“Zydus’s Quadrivalent Inactivated Influenza vaccine VaxiFlu-4 will offer seasonal protection against four new virus strains,” it added. “A quadrivalent vaccine, by covering strains of both ...